CD1C and atherosclerosis: Ro 31-8220 mesylate and saracatinib induced a significant inhibition of most of the specific kinase and TF phosphorylation induced by atherosclerosis plasma (Extended Data Fig. 7c,d), with cell specificity for monocytes and CD1c+ DCs (Fig. 6e,f).